Nitric oxide donor-based cancer therapy: advances and prospects

Z Huang, J Fu, Y Zhang - Journal of medicinal chemistry, 2017 - ACS Publications
The increasing understanding of the role of nitric oxide (NO) in cancer biology has
generated significant progress in the use of NO donor-based therapy to fight cancer. These …

Advanced nitric oxide donors: Chemical structure of NO drugs, NO nanomedicines and biomedical applications

Y Yang, Z Huang, LL Li - Nanoscale, 2021 - pubs.rsc.org
Nitric oxide (NO), as an endogenous diatomic molecule, plays a key regulatory role in many
physiological and pathological processes. This diatomic free radical has been shown to …

Dual intratumoral redox/enzyme‐responsive NO‐releasing nanomedicine for the specific, high‐efficacy, and low‐toxic cancer therapy

X Jia, Y Zhang, Y Zou, Y Wang, D Niu, Q He… - Advanced …, 2018 - Wiley Online Library
Chemotherapy suffers numbers of limitations including poor drug solubility, nonspecific
biodistribution, and inevitable adverse effects on normal tissues. Tumor‐targeted delivery …

Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence

MK Shanmugam, X Dai, AP Kumar, BKH Tan, G Sethi… - Cancer letters, 2014 - Elsevier
Abstract Oleanolic acid (OA, 3β-hydroxyolean-12-en-28-oic acid) is a ubiquitous pentacyclic
multifunctional triterpenoid, widely found in several dietary and medicinal plants. Natural …

Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

Y Gao, H Zhang, F Lirussi, C Garrido, XY Ye… - Biochemical …, 2020 - Elsevier
Epigenetic enzymes histone deacetylases (HDACs) are clinically validated anticancer drug
targets which have been studied intensively in the past few decades. Although several drugs …

Discovery and development of natural product oridonin-inspired anticancer agents

Y Ding, C Ding, N Ye, Z Liu, EA Wold, H Chen… - European journal of …, 2016 - Elsevier
Natural products have historically been, and continue to be, an invaluable source for the
discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in …

Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor

W Duan, J Li, ES Inks, CJ Chou, Y Jia… - Journal of medicinal …, 2015 - ACS Publications
On the basis of the strategy of creating multifunctional drugs, a novel series of
phenylsulfonylfuroxan-based hydroxamates with histone deacetylase (HDAC) inhibitory and …

[HTML][HTML] Heavy metal toxicity in plants and the potential NO-releasing novel techniques as the impending mitigation alternatives

A Pande, BG Mun, NJ Methela, W Rahim… - Frontiers in plant …, 2022 - frontiersin.org
Environmental pollutants like heavy metals are toxic, persistent, and bioaccumulative in
nature. Contamination of agricultural fields with heavy metals not only hampers the quality …

Novel hybrids of 3-substituted coumarin and phenylsulfonylfuroxan as potent antitumor agents with collateral sensitivity against MCF-7/ADR

Z Yu, M Li, K Wang, Y Gu, S Guo, W Wang… - Journal of Medicinal …, 2022 - ACS Publications
Twenty-three new coumarin-furoxan hybrids were synthesized, which exhibited nanomole
antiproliferation activities in A2780, A2780/CDDP, MCF-7/ADR, and MDA-MB-231. Among …

Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies

W Tang, J Xie, S Xu, H Lv, M Lin, S Yuan… - Journal of Medicinal …, 2014 - ACS Publications
Brusatol, a biologically active natural product, was modified in four distinct positions through
the covalent attachment of a furoxan moiety, which acts as a nitric oxide (NO) donor. Forty …